论文部分内容阅读
We discuss group-sequential designs in superiority clinical trials with multiple co-primary endpoints,i.e.,when trials are designed to evaluate if the test intervention is superior to the control on all primary endpoints.We consider several decision-making frameworks for evaluating efficacy or futility,based on boundaries using group-sequential methodology.